Dendreon


Developer and manufacturer focused on cellular immunotherapies and cell therapy manufacturing. The organization supports research and development, clinical and commercial manufacture, logistics, and strategic partnerships to enable patient-specific and complex cell therapies.

Industries

biotechnology
life-science
therapeutics

Nr. of Employees

Very Large (1000+)

Dendreon

Seattle, Washington, United States, North America


Products

FDA-cleared cellular immunotherapy for prostate cancer (commercialized)

A commercially distributed cellular immunotherapy indicated for prostate cancer; noted as the first FDA-approved cellular immunotherapy and received by nearly 40,000 patients.


Services

Cell therapy manufacturing services

Manufacturing services for clinical- and commercial-stage cell therapies, including production workflows, facilities, and distribution support.

Clinical development and outcomes support

Support for clinical research, outcomes tracking, and real-world evidence generation to inform clinical and commercial use of cell therapies.

Supply chain and logistics services for immunotherapies

Operational and logistical services to manage transport, handling, and delivery of cell therapy products, including contingency planning for disruptions.

Expertise Areas

  • Cell therapy manufacturing
  • Cellular immunotherapy development
  • Clinical trial operations for cell therapies
  • Regulatory compliance for biologics and cell therapies
  • Show More (3)

Key Technologies

  • Cellular immunotherapy
  • Cell therapy manufacturing processes
  • Clinical operations for cell therapy trials
  • Cold-chain and biologics logistics
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.